Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese Subjects

EARLY_PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

April 30, 2016

Primary Completion Date

March 11, 2020

Study Completion Date

March 26, 2020

Conditions

Breast Cancer

Interventions

DRUG

Letrozole

Aromatase inhibitor

DIETARY_SUPPLEMENT

Fish Oil

Omega-3 free fatty acid

Trial Locations (2)

Houston Methodist Cancer Center at Texas Medical Center, Houston

Mays Cancer Center, UT Health San Antonio, San Antonio

All Listed Sponsors

lead

The University of Texas Health Science Center at San Antonio

OTHER

NCT02538484 - Impact of Omega 3 Fatty Acid Supplementation on Aromatase in Obese Subjects | Biotech Hunter | Biotech Hunter